查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球癌症登記軟體市場 2023-2030
市場調查報告書
商品編碼
1380247

全球癌症登記軟體市場 2023-2030

Global Cancer Registry Software Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 240 Pages | 商品交期: 2-3個工作天內

價格

隨著癌症盛行率較高和癌症登記軟體的迅速採用，市場可能會成長。然而，患者資料的隱私和安全問題將限制市場成長。然而，政府擴大參與該軟體的推廣可能會為全球癌症登記軟體市場的成長提供有利可圖的機會。

細分市場前景

全球癌症登記軟體市場根據部署模型、資料庫類型和最終用戶產業進行細分。根據部署模型，市場分為基於雲端的和本地的。根據資料庫類型，市場分為商業資料庫和公共資料庫。根據最終用戶行業，市場分為政府和第三方、私人付款人、醫院和醫療實踐等。

醫院和醫療實踐在全球癌症登記軟體市場中佔有相當大的佔有率

到 2022 年，醫院和醫療實踐在全球癌症登記軟體市場中佔據相當大的佔有率。醫院中與癌症相關的手術數量不斷增加，推動了該區域市場的高佔有率。患者一直依賴醫院作為初級保健中心，這可能會推動該細分市場的成長。斯里蘭卡是世界衛生組織東南亞區域的成員國之一，並獲得國際癌症研究機構 (IARC) 以及位於孟買塔塔紀念中心的 IARC 區域中心的癌症登記技術支持， 印度。

對於癌症登記記錄的資料管理，斯里蘭卡國家癌症登記處 (SLNCR) 使用 IARC 開發的開源登記軟體工具 CanReg5。 SLNCR 已收到來自全國 25 個中心的資料。區總醫院、Avissawella、省總醫院、巴杜拉、區總醫院、奇洛、教學醫院、卡盧塔拉姆、區總醫院、綜合醫院、瓦武尼亞和Apeksha 醫院（國家癌症研究所）是目前使用的斯里蘭卡主要醫院癌症登記軟體。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • IBM Corp.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Siemens Healthineers
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • McKesson Corp.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按資料庫類型分類的全球癌症登記軟體市場
    • 商業資料庫
    • 公共資料庫
  • 按部署模式分類的全球癌症登記軟體市場
    • 基於雲端
    • 本地部署
  • 按最終用戶行業分類的全球癌症登記軟體市場
    • 政府及第三方
    • 私人玩家
    • 醫院與醫療實踐
    • 其他

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • C/NET Solutions
  • Conduent, Inc.
  • Electa
  • Electronic Registry System, Inc.
  • Epic Systems
  • ERS, Inc.
  • himagine solutions
  • Inspirata, Inc.
  • NeuralFrame, Inc.
  • Onco, Inc.
  • Ordinal Data Inc
  • Redsson, Ltd.,
  • Rocky Mountain Cancer Data Systems
Product Code: OMR2027748

Title: Global Cancer Registry Software Market Size, Share & Trends Analysis Report, By Deployment Model (On-Premise, Cloud-based), By Database Type (Commercial Database, Public Database), By End-User Industry (Government & Third Party, Private Payers, Hospital & Medical Practice, Others)Forecast Period (2023-2030).

Global cancer registry software market is anticipated to grow at a significant CAGR of 10.5% during the forecast period. The increasing prevalence of cancer, improving quality of care, and reducing healthcare costs along with recent developments by key players are driving the growth of the global cancer registry software market. According to the World Health Organization, Cancer was a leading cause of mortality worldwide, accounting for nearly 10 million mortalities in 2020, or nearly one in six casualties. The most common cancers include breast, lung, colon rectum, and prostate cancers. Additionally, according to estimates from the International Agency for Research on Cancer (IARC) updates from July 2021, by 2040, the global burden of cancers is expected to grow to 27.5 million new cancer cases and 16.3 million casualties globally. Such high burdens will increase the demand for cancer registry software as it would provide significant benefits in identifying the trend related to the prevalence and treatment of cancer.

With high cancer prevalence and rapid adoption of cancer registry software, the market is likely to grow. However, privacy and security concerns for patient data will be a restraint in the market growth. However, the growing involvement of the government in the promotion of this software is likely to offer lucrative opportunities for the growth of the global cancer registry software market.

Segmental Outlook

The global cancer registry software market is segmented based on deployment model, database type, and end-user industry. Based on the deployment model, the market is segmented into cloud-based and on-premises. Based on database type, the market is segmented into commercial databases and public databases. Based on the end-user industry, the market is segmented into government & third party, private payers, hospital & medical practice, and others.

Hospital and Medical Practice Held a Considerable Share in the Global Cancer Registry Software Market

Hospital & medical practice held a considerable share of the global cancer registry software market in 2022. The rising number of cancer-related procedures in hospitals is contributing to the high share of the regional market. Patients have been relying on hospitals as primary care centers, which is likely to drive the growth of this market segment. Sri Lanka is one of the Member States of the World Health Organization's South-East Asia Region and receives technical support for cancer registration from the International Agency for Research on Cancer (IARC), and the IARC Regional Hub based at the Tata Memorial Centre in Mumbai, India.

For data management of cancer registry records, the Sri Lanka National Cancer Registry (SLNCR) uses the open-source registry software tool, CanReg5, as developed by IARC. The SLNCR has received data from 25 centers located across the country. District General Hospital, Avissawella, Provincial General Hospital, Badulla, District General Hospital, Chilaw, Teaching Hospital, Kalutaram, District General Hospital, General Hospital, Vavuniya, and Apeksha Hospital (National Cancer Institute) are the major Sri Lankan Hospitals that are currently using cancer registry software.

Regional Outlook

The global cancer registry software market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America).

Asia-Pacific to exhibit Highest Growth in the Global Cancer registry software Market

Regional growth is attributed to an increasing adoption of technology in the healthcare sector. Also increasing cases of cancer in the region is promoting the adoption of cancer registry software to identify the pattern of cancer for its better treatment. According to the Indian Council of Medical Research-National Cancer Registry Programme (ICMR-NCRP), the government informed Parliament the number of cancer cases in the country is projected to go up from $17.7 million in 2022 to $19.0 million in 2025. For instance, NITI Aayog, the public policy think tank of the Indian Government, aims to build an Imaging Biobank in association with the Department of Biotechnology, wherein it will create a database of cancer-related pathology and radiology images of more than 20,000 profiles of patients. Such images are creating a huge database for cancer registries; thereby driving the regional market growth.

Market Players Outlook

The major companies serving the global cancer registry software market include: IBM Corp., Elekta, McKesson Corp., Siemens Healthineers, and Epic Systems among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2022, Electronic Registry Systems (ERS) Inc. and Nursenav Inc., an oncology navigation software, partnered to integrate their flagship software solutions, CRStar and CONNECT. This integration leverages cancer registry workflows and data collection to support services provided by oncology navigation. The integration between CRStar and CONNECT supports the creation of survivorship care plans by transmitting the diagnosis and treatment data directly into the patient's plan in CONNECT.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global cancer registry software market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. IBM Corp.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Siemens Healthineers
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. McKesson Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Cancer Registry Software Market by Database Type
    • 4.1.1. Commercial Database
    • 4.1.2. Public Database
  • 4.2. Global Cancer Registry Software Market by Deployment Model
    • 4.2.1. Cloud Based
    • 4.2.2. On-Premises
  • 4.3. Global Cancer Registry Software Market by End-User Industry
    • 4.3.1. Government & Third Party
    • 4.3.2. Private Players
    • 4.3.3. Hospital & Medical Practice
    • 4.3.4. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. C/NET Solutions
  • 6.2. Conduent, Inc.
  • 6.3. Electa
  • 6.4. Electronic Registry System, Inc.
  • 6.5. Epic Systems
  • 6.6. ERS, Inc.
  • 6.7. himagine solutions
  • 6.8. Inspirata, Inc.
  • 6.9. NeuralFrame, Inc.
  • 6.10. Onco, Inc.
  • 6.11. Ordinal Data Inc
  • 6.12. Redsson, Ltd.,
  • 6.13. Rocky Mountain Cancer Data Systems

LIST OF TABLES

  • 1. GLOBAL CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL CANCER REGISTRY COMMERCIAL DATABASE SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL CANCER REGISTRY PUBLIC DATABASE SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
  • 5. GLOBAL CLOUD BASED CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL ON-PREMISES CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)
  • 8. GLOBAL CANCER REGISTRY SOFTWARE FOR GOVERNMENT & THIRD PARTY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL CANCER REGISTRY SOFTWARE FOR HEALTHCARE & LIFESCIENCES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL CANCER REGISTRY SOFTWARE FOR HOSPITAL & MEDICAL PRACTICE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL CANCER REGISTRY SOFTWARE FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)
  • 17. EUROPEAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. EUROPEAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
  • 19. EUROPEAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
  • 20. EUROPEAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)
  • 21. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CANCER REGISTRY SOFTWARE MARKET SHARE BY DATABASE TYPE, 2022 VS 2030(%)
  • 2. GLOBAL CANCER REGISTRY SOFTWARE MARKET SHARE BY DEPLOYMENT MODEL, 2022 VS 2030(%)
  • 3. GLOBAL CANCER REGISTRY SOFTWARE MARKET SHARE BY END-USER INDUSTRY, 2022 VS 2030(%)
  • 4. GLOBAL CANCER REGISTRY COMMERCIAL DATABASE MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 5. GLOBAL CANCER REGISTRY PUBLIC DATABASE MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 6. GLOBAL CLOUD BASED CANCER REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 7. GLOBAL ON-PREMISES CANCER REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 8. GLOBAL CANCER REGISTRY SOFTWARE FOR GOVERNMENT & THIRD PARTY MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 9. GLOBAL CANCER REGISTRY SOFTWARE FOR HEALTHCARE & LIFESCIENCES MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 10. GLOBAL CANCER REGISTRY SOFTWARE FOR HOSPITAL & MEDICAL PRACTICE MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 11. GLOBAL CANCER REGISTRY SOFTWARE FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 12. GLOBAL CANCER REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030(%)
  • 13. US CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. CANADA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. UK CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. FRANCE CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. GERMANY CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. ITALY CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. SPAIN CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. REST OF EUROPE CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. INDIA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. CHINA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. JAPAN CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. SOUTH KOREA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. LATIN AMERICA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. MIDDLE EAST AND AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)